๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

43 The discovery and general SAR studies of a novel class of potent non-nucleoside reverse transcriptase inhibitors: R. J. Ternansky1, J. M. Morin, Jr.1, C. Lopez1, C. J. Paget, Jr.1, F. W. Bell1, A. S. Cantrell1, S. R. Jaskunas1, C. L. Jordan1, M. D. Kinnick1, J. A. Palkowitz1, C. A. Parrish1, P. Pranc1, R. T. Vasileff1, S. J. West1, M. Hogberg2, P. Lind2, R. Noreen2, C. Sahlberg2, X.-X. Zhou2, L. Vrang2, C. Rydergard2, C. Ahgren2, B. Oberg2, and N. G. Johansson2. 1Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA; 2Medivir AB, Huddinge, Sweden


Book ID
118393112
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
50 KB
Volume
20
Category
Article
ISSN
0166-3542

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES